Imiglucerase

In the US, Imiglucerase (imiglucerase systemic) is a member of the drug class lysosomal enzymes and is used to treat Gaucher Disease and Thrombocytopenia.

US matches:

• Imiglucerase


• Imiglucerase Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AB02

CAS registry number (Chemical Abstracts Service)

0154248-97-2

Chemical Formula

C2532-H3843-N671-O711-S16

Molecular Weight

55575

Therapeutic Category

Enzyme, replacement therapy

Chemical Name

495-L-Histidineglucosylceramidase (human placenta isoenzyme protein moiety)

Foreign Names

• Imiglucerasum (Latin)
• Imiglucerase (German)
• Imiglucérase (French)
• Imiglucerasa (Spanish)

Generic Names

• Imiglucerase (OS: USAN, BAN)
• Imiglucérase (OS: DCF)
• Alglucerase, gentechnisch hergestellt (IS)

Brand Names

• Cerezyme
  Genzyme, Austria; Genzyme, Australia; Genzyme, Belgium; Genzyme, Bulgaria; Genzyme, Canada; Genzyme, Switzerland; Genzyme, China; Genzyme, Czech Republic; Genzyme, Germany; Genzyme, Denmark; Genzyme, Spain; Genzyme, Finland; Genzyme, France; Genzyme, United Kingdom; Genzyme, Greece; Genzyme, Israel; Genzyme, Italy; Genzyme, Luxembourg; Genzyme, Netherlands; Genzyme, Norway; Genzyme, New Zealand; Genzyme, Romania; Genzyme, Serbia; Genzyme, Sweden; Genzyme, Slovenia; Genzyme, Slovakia; Genzyme, United States; Genzyme Nippon, Japan; Medical Intertrade, Croatia (Hrvatska); Vantone, Hong Kong

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.